APMDApnimed Inc. Common Stock
28.83USD-9.97%Mkt Cap: 1.28B $P/E: 9.28

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an ora…

HeadlineSourceTime
Yesterday
Moderna's Melanoma Result Landed On A Market Positioned The Other Way

The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short sellers in the stock took a record single-session loss.

Trefis
Older
Apnimed (APMD) Joins The NASDAQ Composite Index

Apnimed (NasdaqGS:APMD) has been added to the NASDAQ Composite Index, increasing its visibility among index-following investors. Inclusion in the index can lead to higher trading liquidity as more funds and investors track or reference the NASDAQ Composite. The move is often viewed as recognition of a company’s progress and operational milestones within the public markets. For a broader view on companies gaining fresh attention from index inclusions and other milestones, explore the wider...

Simply Wall St.
Stock Market, IPO Leaders Rally To New Highs. Check This Screen Daily.

Stock market leaders are becoming plentiful as the S&P 500 probes all-time highs. Recent IPO Bending Spoons clears an IPO base.

Investor's Business Daily